Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis (Q34096625)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis
scientific article

    Statements

    Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis (English)
    Iuga Liepelt
    Alexandra Gaenslen
    Adriana Di Santo
    Katharine J Schweitzer

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit